OPRK1 and major depressive disorder: Regarding the clinical utility of selective KOR antagonists for mood disorders, though both the negative affect/dysphoria model and the novelty processing model predict that KOR antagonism could reduce depression and excessive drug use, the two frameworks diverge regarding implementation strategy.